How much is Outpace Bio worth in 2026?

Outpace Bio has a current valuation of $220.0M based on their Early Stage VC round and secondary market data.

How much funding has Outpace Bio raised?

Outpace Bio has raised $199.0M in total funding across 1 funding rounds.

Outpace Bio

Discovery Tools (Healthcare)Website

Outpace Bio valuation and funding history | Last updated: July 17, 2024 | 1 funding rounds

Current Valuation

$220.0M

As of July 17, 2024

Total Funding Raised

$199.0M

Across 1 round

Last Round

Early Stage VC

$144.0M

Last Funding

Jul 2024

Funding date

Capital Efficiency

1.11x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
July 17, 2024	Early Stage VC (Series B)	$144.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Outpace Bio is currently valued at $220.0M as of July 17, 2024. The company has raised a total of $199.0M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 1.11x, Outpace Bio has achieved a valuation that is 1.11 times the total capital raised.

Track Outpace Bio Valuation Updates

Get notified when Outpace Bio raises new funding or valuation changes

Explore More Data

Detailed analysis for Outpace Bio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Outpace Bio's valuation history, funding rounds, and growth metrics.

No credit card required

What is Outpace Bio Worth in 2026?

Outpace Bio is a leading private company in the Discovery Tools (Healthcare) sector. Track Outpace Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Outpace Bio Valuation is Determined

Private company valuations like Outpace Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.